Here are some of the major companies whose stocks moved on the week’s news.

U.S. stocks were pulling back from record territory in the final hour of trade Thursday as investors looked forward to big ...

ETFs such as The Schwab US Dividend ETF can be useful, but a 'DIY' approach can help you outperform. Here are 3 of the best ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Pfizer (PFE – Research Report), with a price ...

Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating on October 7. David ...

There was some intriguing news from a Pfizer (NYSE: PFE) shareholder on Thursday that was not taken well by the market.

US stocks declined on Thursday, with the S&P 500 and Dow Jones Industrial Average retreating from record highs amid signs of ...

US Treasuries and stock futures endured a bout of volatility as investors weighed economic data releases showing a smaller than expected decline in inflation and the highest level of jobless claims in ...

Pfizer ( PFE 3.46%) was a stock on the move Wednesday, and not because of any news generated by the healthcare company.

While shares have posted break-even returns so far in 2024, Pfizer stock has cratered by more than 30% over the ...

Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...

Stocks fell as traders trimmed their bets on Federal Reserve rate cuts, sending Treasury 10-year yields above 4%. Oil rallied ...